IC
Immunosyn Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Miceli James T, was filed 15 Apr 2010.
Immunosyn Corp: what insiders have been doing
This page follows insider dealings at Immunosyn Corp as filed with SEC (Form 4). Nothing new has been filed by managers of Immunosyn Corp in twelve months, the latest record being from 15 April 2010.
Our records for Immunosyn Corp go back to 2007, with 29 purchases and 61 sales on the open market in total.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
114
Thresholds
n/a
Buy Volume
€17B
29 ops. · all time
Sell Volume
€39B
61 ops. · all time
Last declaration on 15 April 2010
Declarations114 total
- 574,677 shares@ US$4.15Common StockSEC:0001437749-10-001098:0
- 500,000 shares0Common StockSEC:0001437749-10-001099:0
- 12,710,000 shares0Common StockSEC:0001437749-10-001099:1
- 500,000 shares0Common StockSEC:0001437749-10-001101:0
- 12,710,000 shares0Common StockSEC:0001437749-10-001101:1
- 10,000 shares0Common StockSEC:0001437749-10-001097:1
- 10,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:2Canonical exit: 5 Oct 2009 (T+90)
- 21,500 shares@ US$0.08Common StockSEC:0001437749-10-001101:3Canonical exit: 6 Oct 2009 (T+90)
- 15,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:4Canonical exit: 6 Oct 2009 (T+90)
- 10,000 shares@ US$0.08Common StockSEC:0001437749-10-001101:5Canonical exit: 11 Oct 2009 (T+90)
- 10,000 shares@ US$0.095Common StockSEC:0001437749-10-001101:6Canonical exit: 12 Oct 2009 (T+90)
- 10,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:7Canonical exit: 12 Oct 2009 (T+90)
- 51,500 shares@ US$0.09Common StockSEC:0001437749-10-001101:8Canonical exit: 13 Oct 2009 (T+90)
- 10,000 shares@ US$0.095Common StockSEC:0001437749-10-001101:9Canonical exit: 13 Oct 2009 (T+90)
- 50,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:10Canonical exit: 28 Sept 2009 (T+90)
- 2,857 shares@ US$0.06Common StockSEC:0001437749-10-001101:11Canonical exit: 4 Oct 2009 (T+90)
- 10,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:12Canonical exit: 8 Oct 2009 (T+90)
- 30,000 shares@ US$0.09Common StockSEC:0001437749-10-001101:13Canonical exit: 12 Oct 2009 (T+90)
- 12,780 shares@ US$0.08Common StockSEC:0001437749-10-001101:14Canonical exit: 18 Oct 2009 (T+90)
- 50,000 shares@ US$0.08Common StockSEC:0001437749-10-001101:15Canonical exit: 20 Oct 2009 (T+90)
- 2,500 shares@ US$0.07Common StockSEC:0001437749-10-001101:16Canonical exit: 20 Oct 2009 (T+90)
- 50,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:17Canonical exit: 25 Oct 2009 (T+90)
- 50,000 shares@ US$0.07Common StockSEC:0001437749-10-001101:18Canonical exit: 26 Oct 2009 (T+90)
- 77,000 shares@ US$0.06Common StockSEC:0001437749-10-001101:19Canonical exit: 24 Nov 2009 (T+90)
- 100,000 shares@ US$0.05Common StockSEC:0001437749-10-001101:20Canonical exit: 29 Nov 2009 (T+90)
25 of 114 declarations
About Immunosyn Corp
Immunosyn Corp is a company listed on the XNAS market, specializing in the development of immunological solutions. It focuses on research and innovation in the field of immune therapies.
